Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Livia Veress to Fibrin

This is a "connection" page, showing publications Livia Veress has written about Fibrin.

 
Connection Strength
 
 
 
0.464
 
  1. Liptzin DR, McGraw MD, Houin PR, Veress LA. Fibrin airway cast obstruction: Experience, classification, and treatment guideline from Denver. Pediatr Pulmonol. 2022 02; 57(2):529-537.
    View in: PubMed
    Score: 0.192
  2. Veress LA, Hendry-Hofer TB, Loader JE, Rioux JS, Garlick RB, White CW. Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am J Respir Cell Mol Biol. 2013 Apr; 48(4):439-47.
    View in: PubMed
    Score: 0.106
  3. Veress LA, O'Neill HC, Hendry-Hofer TB, Loader JE, Rancourt RC, White CW. Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. Am J Respir Crit Care Med. 2010 Dec 01; 182(11):1352-61.
    View in: PubMed
    Score: 0.088
  4. Bodmer JL, Weinman J, Veress LA, Galambos C. Obstructive Bronchial Fibrin Cast Formation in COVID-19 Severe Respiratory Failure. Am J Respir Crit Care Med. 2023 02 01; 207(3):349-350.
    View in: PubMed
    Score: 0.052
  5. Rancourt RC, Veress LA, Ahmad A, Hendry-Hofer TB, Rioux JS, Garlick RB, White CW. Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation. Toxicol Appl Pharmacol. 2013 Oct 01; 272(1):86-95.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)